Pfizer Asks FDA to Authorize 3 COVID-19 Vaccine Doses for Children Under 5

Says study suggests 3 doses 80 percent effective in preventing symptomatic COVID-19

A firefighter prepares pediatric doses of the Pfizer-BioNtech COVID-19 vaccine in Shoreline, Washington, on Nov. 3, 2021. David Ryder/Getty Images

Pfizer and BioNTech have completed an application for emergency use authorization (EUA) to the Food and Drug Administration (FDA) for a three-dose COVID-19 vaccine regimen for children aged 6 months to under 5 years old.

Pfizer announced the completion of its EUA application on Wednesday, reported multiple outlets.